These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31782605)

  • 1. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
    Seiwell AP; Buckley K; Pettenati M; Grier DD
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of SUPT3H as a novel 8q24/MYC partner in blastic plasmacytoid dendritic cell neoplasm with t(6;8)(p21;q24) translocation.
    Nakamura Y; Kayano H; Kakegawa E; Miyazaki H; Nagai T; Uchida Y; Ito Y; Wakimoto N; Mori S; Bessho M
    Blood Cancer J; 2015 Apr; 5(4):e301. PubMed ID: 25860292
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated blastic plasmacytoid dendritic cell neoplasm.
    Loghavi S; Khoury JD
    Blood; 2015 Jul; 126(4):558. PubMed ID: 26421330
    [No Abstract]   [Full Text] [Related]  

  • 4. MicroRNA profiling of blastic plasmacytoid dendritic cell neoplasm and myeloid sarcoma.
    Sapienza MR; Fuligni F; Melle F; Tabanelli V; Indio V; Laginestra MA; Motta G; Mazzara S; Cerroni L; Pileri A; Facchetti F; Paulli M; Cascione L; Laganà A; Berti E; Ferracin M; Agostinelli C; Sabattini E; Croce CM; Pileri SA
    Hematol Oncol; 2020 Dec; 38(5):831-833. PubMed ID: 33405278
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
    Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
    Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The distinctive cytology and disease evolution of blastic plasmacytoid dendritic cell neoplasm.
    Fernandes F; Barreira R; Cortez J; Silveira M; Bain BJ
    Am J Hematol; 2018 Nov; 93(11):1431-1432. PubMed ID: 30020546
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
    Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
    Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of blastic plasmacytoid dendritic cell neoplasm with translocations involving the MYC locus identifies t(6;8)(p21;q24) as a recurrent cytogenetic abnormality.
    Sumarriva Lezama L; Chisholm KM; Carneal E; Nagy A; Cascio MJ; Yan J; Chang CC; Cherry A; George TI; Ohgami RS
    Histopathology; 2018 Nov; 73(5):767-776. PubMed ID: 29884995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of disseminated blastic plasmocytoid dendritic cell neoplasm.
    Loscocco GG; Piccini M; Vergoni F; Vannucchi AM; Bosi A
    Am J Hematol; 2018 Nov; 93(11):1433-1434. PubMed ID: 29664121
    [No Abstract]   [Full Text] [Related]  

  • 11. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
    Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
    Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations.
    Kurt H; Khoury JD; Medeiros LJ; Huh YO
    Br J Haematol; 2018 May; 181(3):305. PubMed ID: 29411884
    [No Abstract]   [Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles.
    Lyapichev KA; Sukswai N; Konoplev S; Khoury JD
    Ann Hematol; 2019 Sep; 98(9):2221-2222. PubMed ID: 30955062
    [No Abstract]   [Full Text] [Related]  

  • 14. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
    Mizia-Malarz A; Sobol-Milejska G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blastic Plasmacytoid Dendritic Cell Neoplasm: First Case Report From Rwanda and Review of the Literature.
    Ruhangaza D; Mugabe MC; Kigonya CN; Lane AA; Morgan EA
    J Glob Oncol; 2019 Jun; 5():1-6. PubMed ID: 31246550
    [No Abstract]   [Full Text] [Related]  

  • 16. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies.
    Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A
    Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms.
    Boddu PC; Wang SA; Pemmaraju N; Tang Z; Hu S; Li S; Xu J; Medeiros LJ; Tang G
    Leuk Res; 2018 Mar; 66():73-78. PubMed ID: 29407586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia.
    Loh ML; Samson Y; Motte E; Moreau LA; Dalton V; Waters S; Sallan SE; Gilliland DG
    Cancer Genet Cytogenet; 2000 Oct; 122(2):79-82. PubMed ID: 11106815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.
    De Jong D; Voetdijk BM; Beverstock GC; van Ommen GJ; Willemze R; Kluin PM
    N Engl J Med; 1988 May; 318(21):1373-8. PubMed ID: 3285208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.